Package 64980-449-03

Brand: fingolimod

Generic: fingolimod hcl
NDC Package

Package Facts

Identity

Package NDC 64980-449-03
Digits Only 6498044903
Product NDC 64980-449
Product ID 64980-449_2622c15a-3781-3016-e063-6294a90a84d5
Description

30 CAPSULE in 1 BOTTLE (64980-449-03)

Marketing

Marketing Status
Marketed Since 2023-09-04
Brand fingolimod
Generic fingolimod hcl
Sample Package No

Linked Drug Pages (1)

fingolimod ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2622c15a-3781-3016-e063-6294a90a84d5", "openfda": {"upc": ["0364980449038"], "unii": ["G926EC510T"], "rxcui": ["1012895"], "spl_set_id": ["99e7daf4-ea90-5e47-e053-2a95a90ac1b7"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (64980-449-03)", "package_ndc": "64980-449-03", "marketing_start_date": "20230904"}], "brand_name": "fingolimod", "product_id": "64980-449_2622c15a-3781-3016-e063-6294a90a84d5", "dosage_form": "CAPSULE", "pharm_class": ["Sphingosine 1-Phosphate Receptor Modulators [MoA]", "Sphingosine 1-phosphate Receptor Modulator [EPC]"], "product_ndc": "64980-449", "generic_name": "Fingolimod hcl", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "fingolimod", "active_ingredients": [{"name": "FINGOLIMOD HYDROCHLORIDE", "strength": ".5 mg/1"}], "application_number": "ANDA207939", "marketing_category": "ANDA", "marketing_start_date": "20211110", "listing_expiration_date": "20261231"}